Core Viewpoint - Starting from today, all designated medical institutions in China must scan the "drug traceability code" for drug sales, which is essential for medical insurance fund settlement. By January 1, 2026, all medical institutions are required to fully collect and upload drug traceability codes [1][10]. Drug Traceability Code Scanning Process - The process for scanning the drug traceability code involves accessing the National Medical Insurance Bureau's WeChat public account, selecting the service option, and entering the drug traceability information query page [1][2]. - The scanning results can yield four possible outcomes, ranging from no sales information found to multiple sales records indicating potential issues with the drug's legitimacy [3][4][5]. Types of Traceability Codes - Traceability codes are categorized into three levels: large code, medium code, and small code, each serving different packaging units and purposes [6][7][9]. - The smallest traceability code is assigned to individual boxes, while medium and large codes are used for larger packaging, facilitating easier verification for companies [9]. Implementation and Regulation - Since the nationwide implementation of drug traceability code collection began in 2024, a total of 39.885 billion traceability codes have been aggregated [10]. - The National Medical Insurance Bureau has identified and is addressing fraudulent activities related to the sale of "returned drugs" and other illegal practices [15][17]. Consumer Rights and Responsibilities - Consumers are advised to follow six principles when purchasing drugs to protect their rights, including ensuring the presence of a traceability code, verifying the code during payment, and retaining receipts [18].

Core Viewpoint - The implementation of drug traceability codes starting from July 1 aims to enhance the management of medical insurance drugs and combat fraud in the healthcare system [1][3][4]. Group 1: Drug Traceability Code Implementation - From July 1, all designated medical institutions must record the full traceability information of drugs sold under medical insurance, adhering to the standards of "full collection, code-based settlement, and code-based payment" [3][4]. - The traceability code serves as a unique "electronic ID" for each drug, ensuring that each box of medicine has a distinct code that cannot be replicated [4][5]. - By January 1, 2026, all medical institutions must fully upload traceability codes, establishing a complete drug traceability loop [4][5]. Group 2: Consumer Protection and Rights - Consumers can verify the sales history of a drug using the traceability code, which can serve as crucial evidence for protecting their rights [7][8]. - The National Medical Insurance Administration provides guidelines for consumers to ensure they only purchase drugs with valid traceability codes and to report any suspicious sales [8][9]. - Legal provisions allow consumers to claim significant compensation for purchasing counterfeit or substandard drugs, reinforcing consumer rights [8][9]. Group 3: Impact on the Pharmaceutical Industry - The traceability system is expected to reduce management costs by approximately 20% and improve operational efficiency by over 30% for pharmaceutical companies [10]. - The comprehensive application of drug traceability codes is anticipated to create a healthier and more compliant ecosystem in the pharmacy industry, facilitating a smoother implementation of policies [10][11]. - The transition to a digitalized pharmaceutical industry is seen as a new starting point for the sector, potentially leading to a surge in innovative drug listings [11].

Group 1 - The implementation of drug traceability codes will reshape the management ecosystem of medical insurance drugs in China, with a focus on preventing fraud and ensuring compliance [2][4][9] - Starting from July 1, 2025, new drug purchases must be scanned for traceability codes to settle medical insurance claims, while existing unmarked drugs will be managed under a transitional "unmarked library" [3][4] - By January 1, 2026, all medical institutions must fully collect traceability codes, establishing a complete drug traceability loop [3] Group 2 - The unique design of traceability codes, which includes features like uniqueness and detailed management, is crucial for regulatory effectiveness [2] - As of March 20, 2025, over 350 pharmaceutical production and distribution companies have connected to the traceability platform, with nearly 8,000 companies inquiring about the upload and query process [2] - The traceability code system is expected to reduce management costs by 20% and improve operational efficiency by over 30% for companies integrating with the national traceability platform [7] Group 3 - Consumers can verify drug sales and protect their rights using traceability codes, which should only have one sales record [6] - The current legal framework provides strong protections for consumers against fraud, allowing for significant compensation in cases of selling counterfeit drugs [7] - The comprehensive application of traceability codes is seen as a new starting point for the digital transformation of the pharmaceutical industry [9]

Core Points - Starting from July 1, medical institutions designated for medical insurance must scan the drug traceability code before settling with the medical insurance fund; by January 1, 2026, all medical institutions must fully collect and upload drug traceability codes [1] - The drug traceability code serves as the "electronic ID" for drugs, ensuring that each box of medication has a unique scanning record, preventing the sale of counterfeit, returned, or swapped drugs [1] - Consumers can use the National Medical Insurance Administration's WeChat public account to scan the traceability code on drug packaging to obtain detailed sales information [1] Drug Traceability Code Usage - To check drug sales information, consumers can follow these steps: access the National Medical Insurance Administration's WeChat public account, navigate to the drug traceability information query, and scan the QR code or barcode on the drug packaging [1] - If the query shows "only 1 sales record," it indicates the drug is legal and compliant if it matches the consumer's purchase; otherwise, it may indicate the drug has been resold, potentially being a returned, swapped, or counterfeit drug [2] - If the query shows "2 or more sales records," it suggests the drug has been sold previously; information obtained from non-official software or apps may not reflect the drug's medical insurance sales settlement information [3]

Core Viewpoint - The implementation of drug traceability codes starting from July 1, 2025, is expected to enhance the traceability of medical insurance drugs, strengthen drug circulation supervision, and have a profound impact on the pharmaceutical industry chain, including production, circulation, retail, and medical insurance [1][5][6]. Group 1: Implementation and Impact - The National Medical Insurance Administration has mandated that drug traceability codes must be scanned for medical insurance fund settlement starting July 1, 2025, with full collection and upload of traceability codes required by January 1, 2026 [1][5]. - The traceability code serves as an "electronic ID" for each box of medicine, ensuring unique scanning records to prevent counterfeit drugs and ensure proper drug flow [2][5]. - The traceability system is expected to reduce channel management costs by over 20% and improve operational efficiency by over 30% for companies that fully implement data uploads [3]. Group 2: Industry Response - Several listed companies are actively responding to the regulatory changes, showcasing their efforts in drug traceability and related fields [3][4]. - Companies like Guizhou Xinbang Pharmaceutical have reported significant improvements in procurement, production, storage, and circulation processes due to the new traceability platform [3]. - National Health has emphasized its commitment to data integration and service upgrades to support the traceability initiative, indicating a deep layout in drug regulatory information technology [4]. Group 3: Regulatory and Financial Implications - The traceability code is expected to enhance transparency in drug circulation, reduce logistics costs, and promote fair competition based on quality, price, and service [6][7]. - The integration of traceability data is anticipated to facilitate innovative regulatory models and improve the precision of medical insurance management [6][7]. - The shift towards data-driven credit assessments in the pharmaceutical supply chain is expected to alleviate financing challenges for pharmaceutical companies and foster diverse financial products [7].

2025.06. 30 本文字数：693，阅读时长大约2分钟 据国家医保局，药品追溯码就是每盒药品的"电子身份证"，具有唯一性。一盒药品的追溯码，只应 有一次被扫码销售的记录，若重复出现多次，就存在假药、回流药或药品被串换销售的可能。2024 年4月以来，国家医保局全力开展医保药品耗材追溯信息采集应用工作，取得显著进展。 现在，通过国家医保局微信公众号扫描药盒上的药品追溯码，即可获取详细的药品销售信息，了解药 品的"前世今生"，具体查询方法来看下方攻略。 第一步 ： 进入 "国家医保局"微信公众号主页 ，点击服务→药品追溯信息查询，进入查询页面； 或进入 "国家医保局"微信公众号消息对话页， 点击医保服务→药品追溯信息查询，进入查询页面。 国家医保局 指甲修剪细节藏门道! 浙江省首期长期照护师 培训开班 昨天 15:02 服护师职业技能等级证书 好 全 T THE 广东颁发首批长期照护师职业技能等级证书, 多举措赋能长护险发展 c == == 药品追溯信息查询 ✆ 47 型 国家医保服务平台 (2 国家医保药品目录查询 ✆ 第二步： 在"药品信息查询"页面，可扫描药品包装盒上的二维码或条形码进行查询。 09: ...

Group 1 - The event "Industrial and Information Lecture Hall" focused on the digital transformation of the biopharmaceutical industry, with over 100 participants including government officials and industry representatives [1][3] - The event included site visits to Hengxiutang Pharmaceutical Co., Ltd. and Sinocare Inc., where attendees learned about digital transformation experiences [3] - More than 100 small and medium-sized enterprises in Changsha's biopharmaceutical sector are participating in the third batch of transformation trials, creating multiple typical application scenarios and innovative dual-line integration models [3] Group 2 - Hengxiutang Pharmaceutical's digital transformation leader shared insights on the underlying logic and implementation paths of digital transformation, addressing pain points in traditional Chinese medicine manufacturing [3] - The next steps for the industrial system include building a "government-industry-university-research-application" platform to tackle common technologies like AI quality control and drug traceability [3] - The initiative aims to support benchmark enterprises in sharing transformation experiences and encourage personalized intelligent manufacturing scenarios, while also focusing on cultivating interdisciplinary talent through collaboration with universities and research institutions [3]

Core Viewpoint - The National Healthcare Security Administration (NHSA) has implemented a drug traceability code scanning service via WeChat, in collaboration with Tencent, to enhance drug safety and combat fraud in the pharmaceutical sector [1][2]. Group 1: Drug Traceability Implementation - The NHSA is advancing strict regulation through the use of drug traceability codes to combat fraud and illegal activities in the pharmaceutical field, including the crackdown on "returned drugs" and "swapped drugs" [2]. - Users can verify drug sales records and obtain information on indications, usage, and dosage through WeChat's "Scan" feature, ensuring safe medication practices [1][3]. Group 2: User Experience and Features - The WeChat "Scan" feature allows users to check the sales records of both prescription and OTC drugs purchased from pharmacies, providing a comprehensive verification of drug sources [3]. - Users can receive one of three possible results when scanning a drug traceability code: no sales information found, one valid sales record, or multiple sales records indicating potential illegal activities [5]. - Starting July 1, 2023, designated medical institutions must scan codes for drug sales to settle insurance funds, with full implementation required by January 1, 2026, ensuring all drug transactions are traceable [5]. Group 3: Additional Services - The Tencent Health Box offers intelligent medication reminders, allowing users to set reminders for multiple medications, track interactions, and visualize their medication history, particularly beneficial for chronic disease patients [7].